Erratum: Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: Rapid review (The BMJ (2020) 369 (m1936) DOI: 10.1136/bmj.m1936);Scope, quality, and inclusivity of clinical guidelines produced early in the covid-19 pandemic: Rapid review

The BMJ

Volumn 369, Issue , 2020, Pages

  Dagens, Andrew ^a   Sigfrid, Louise ^a   Cai, Erhui ^a   Lipworth, Sam ^b   Cheung, Vincent ^a   Harris, Eli ^a   Bannister, Peter ^c   Rigby, Ishmeala ^a   Horby, Peter ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c BRIGHTON AND SUSSEX MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; CHLOROQUINE; CICLESONIDE; CORTICOSTEROID; FAVIPIRAVIR; HYDROXYCHLOROQUINE; LOPINAVIR PLUS RITONAVIR; NONSTEROID ANTIINFLAMMATORY AGENT; OXYGEN; RECOMBINANT BETA INTERFERON; REMDESIVIR;

CONTENT ANALYSIS; CORONAVIRUS DISEASE 2019; DRUG USE; EDITORIAL; GLOBAL HEALTH; GOVERNMENTAL ORGANIZATION; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HUMAN; INFECTION PREVENTION; MEDICAL RESEARCH; METHODOLOGY; MIDDLE EAST RESPIRATORY SYNDROME; NON-GOVERNMENTAL ORGANIZATION; NONINVASIVE VENTILATION; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; STAKEHOLDER ENGAGEMENT; SYSTEMATIC REVIEW; VULNERABLE POPULATION; WORLD HEALTH ORGANIZATION; BETACORONAVIRUS; COMPLICATION; CORONAVIRUS INFECTION; OXYGEN THERAPY; VENOUS THROMBOEMBOLISM; VIRUS PNEUMONIA;

ADRENAL CORTEX HORMONES; ANTIVIRAL AGENTS; BETACORONAVIRUS; CORONAVIRUS INFECTIONS; HUMANS; OXYGEN INHALATION THERAPY; PANDEMICS; PNEUMONIA, VIRAL; PRACTICE GUIDELINES AS TOPIC; SEVERE ACUTE RESPIRATORY SYNDROME; VENOUS THROMBOEMBOLISM; VULNERABLE POPULATIONS; WORLD HEALTH ORGANIZATION;

EID: 85085539734     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.m2371     Document Type: Erratum

References (41)

1. Graham R, Mancher M, eds. Institute of Medicine Committee on standards for developing trustworthy clinical practice guidelines. Clinical practice guidelines we can trust. Washington, DC, National Academies Press, 2011. doi:10. 17226/13058.
2. Brouwers MCKK, Kerkvliet K, Spithoff K, AGREE Next Steps Consortium. The AGREE Reporting Checklist: A tool to improve reporting of clinical practice guidelines. BMJ 2016;352:i1152. doi:10. 1136/bmj. i1152
3. Norris SL, Sawin VI, Ferri M, Reques Sastre L, Porgo TV. An evaluation of emergency guidelines issued by the World Health Organization in response to four infectious disease outbreaks [correction: PLoS One 2018;13:e0202782]. PLoS One 2018;13:e0198125. doi:10. 1371/ journal. pone. 0198125
4. Sinclair D, Isba R, Kredo T, Zani B, Smith H, Garner P. World Health Organization guideline development: An evaluation [correction: PLoS One 2013;8]. PLoS One 2013;8:e63715. doi:10. 1371/journal. pone. 0063715
5. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: A retrospective cohort study. Lancet 2020;395:1054-62. doi:10. 1016/S0140-6736(20)30566-3
6. Dagens A. Rapid review of the availability, quality and inclusivity of clinical guidelines for covid 19 open science framework. 2020. https://osf. io/c6nqv/.
7. Health Canadian Agency for Drugs and Technologies in Health. Strings attached: CADTH's database search filters. 2019. https:// www. cadth. ca/resources/finding-evidence/strings-attached-cadthsdatabase-search-filtersguide.
8. Johnston A, Kelly SE, Hsieh SC, Skidmore B, Wells GA. Systematic reviews of clinical practice guidelines: A methodological guide. J Clin Epidemiol 2019;108:64-76. doi:10. 1016/j. jclinepi. 2018. 11. 030
9. World Health Organization. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected: Interim guidance. WHO, 2020. https://www. who. int/ publications-detail/clinical-management-of-severe-acute-respiratoryinfection-when-novel-coronavirus-(ncov)-infection-is-suspected.
10. Ministerio de Sanidad. Protocol for clinical management of the novel coronavirus. 2020.
11. COREM Mission Nationale. [Expert Recommendations on the management of intensive care patients during the SARS-CoV2 epidemic. ] 2020. https://sfar. org/recommandations-dexpertsportant-sur-la-prise-en-charge-en-reanimation-des-patients-enperiode-depidemie-a-sars-cov2/.
12. Hinweise zu Erkennung. Diagnosis and treatment of patiens with COVID-19. Robert Koch Institute, 2020.
13. Department of Health, Jakarta. Guidelines for coronavirus disease (covid-19). 2019.
14. Ministry of Health and Welfare. Guidelines on Clinical management of severe acute respiratory illness (SARI) in suspect/confirmed novel coronavirus (nCoV) cases. 2020. https://ncdc. gov. in/WriteReadData/ l892s/96997299691580715786. pdf.
15. Società Italiana di Malattie Infettive e Tropicali. [Therapeutic andsSupportive care guidelines for patients with COVID-19 coronavirus. ] 2020. http://www. fvcalabria. unicz. it/COVID-19/LINEEGUIDA/ linee-guida-SIMIT-marzo-2020. pdf.
16. Japanese Association of Infectious Diseases. Concept of antiretroviral treatment for COVID 19. 1st edition. 2020.
17. Office of the Deputy Director-General of Health (Public Health). Guidance on covid-19 management in Malaysia. Department of Public Health, 2020.
18. Working Group on COVID 2019 in the Russian Federation. Russia prevention, diagnosis and treatment of new coronavirus infection (covid-19): Temporary guidelines. 2020.
19. Saudi Arabian Centre for Disease Control. Coronavirus disease 19 (COVID-2019) guidelines. 2020. https://www. moh. gov. sa/CCC/ healthp/regulations/Documents/Coronavirus%20Disease%20 2019%20Guidelines%20v1. 1. pdf.
20. Korea covid-19 Central Clinical Task Force. Antimicrobial therapy recommendation. 2020.
21. Ministerio de Sanitarias (Madrid). Technical document on the Clinical Management of Patients with novel Coronavirus (COVID019). 2020.
22. Taiwan Centers for Disease Control. Interim clinical guidance for management of patients with SARS-CoV-2 infection. 2020. https:// www. cdc. gov. Tw/File/Get/-ewtg9-RCAetCPKR4-rnCw.
23. Ministry of Health. Turkey COVID-19 (2019-nCoV disease) directory. 2020. https://covid19bilgi. saglik. gov. Tr/tr/.
24. Centers for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease. 2019 (COVID-19). 2020. https://www. cdc. gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients. html.
25. National Health Commission of China. Diagnosis and treatment protocols for patients with novel coronavirus pneumonia. 2020. https://www. chinadaily. com. cn/pdf/2020/1. Clinical. Protocols. for. The. Diagnosis. And. Treatment. of. COVID-19. V7. pdf.
26. Vollaard A, Gieling E, de Boer M, Erik Snijder E, van Dissel J. Pharmaceutical Treatment Strategies for patients with COVID-19. Rijksinstituut voor Volksgezondheid en Milieu, 2020.
27. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006;3:e343. doi:10. 1371/journal. pmed. 0030343
28. Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2016;3:CD010406. doi:10. 1002/14651858. CD010406. pub2
29. Delaney JW, Pinto R, Long J, et al, Canadian Critical Care Trials Group H1N1 Collaborative. The influence of corticosteroid treatment on the outcome of influenza A(H1N1pdm09)-related critical illness. Crit Care 2016;20:75. doi:10. 1186/s13054-016-1230-8
30. Arabi YM, Mandourah Y, Al-Hameed F, et al, Saudi Critical Care Trial Group. Corticosteroid therapy for critically ill patients with middle east respiratory syndrome. Am J Respir Crit Care Med 2018;197:757-67. doi:10. 1164/rccm. 201706-1172OC
31. Villar J, Ferrando C, Martínez D, et al, dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: A multicentre, randomised controlled trial. Lancet Respir Med 2020;8:267-76. doi:10. 1016/S2213-2600(19)30417-5
32. Zumla A, Hui DS, Perlman S. Middle East respiratory syndrome. Lancet 2015;386:995-1007. doi:10. 1016/S0140-6736(15)60454-8
33. Russell CD, Millar JE, Baillie JK. Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 2020;395:473-5. doi:10. 1016/S0140-6736(20)30317-2
34. Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med 2019;200:e45-67. doi:10. 1164/rccm. 201908-1581ST
35. World Health Organization. Clinical management of severe acute respiratory infection when Middle East respiratory syndrome coronavirus (MERS-CoV) infection is suspected. 2019. https://apps. who. int/iris/ bitstream/handle/10665/178529/WHO-MERS-Clinical-15. 1-eng. pdf.
36. World Health Organization. WHO handbook for guidelines development. 2nd ed. WHO, 2019.
37. Rodriguez A, Alvarez-Rocha L, Sirvent JM, et al. [Recommendations of the Infectious Diseases Work Group (GTEI) of the Spanish Society of Intensive and Critical Care Medicine and Coronary Units (SEMICYUC) and the Infections in Critically Ill Patients Study Group (GEIPC) of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) for the diagnosis and treatment of influenza A/ H1N1 in seriously ill adults admitted to the intensive care unit]. Med Intensive 2012;36:103-37. doi:10. 1016/j. medin. 2011. 11. 020.
38. Lim WS, British Infection Society, British Thoracic Society, Health Protection Agency. Pandemic flu: clinical management of patients with an influenza-like illness during an influenza pandemic. Provisional guidelines from the British Infection Society, British Thoracic Society, and Health Protection Agency in collaboration with the Department of Health. Thorax 2007;62(Suppl 1):1-46. doi:10. 1136/thx. 2006. 073080
39. Woodhead M, Blasi F, Ewig S, et al, Joint Taskforce of the European Respiratory Society and European Society for Clinical Microbiology and Infectious Diseases. Guidelines for the management of adult lower respiratory tract infections-summary. Clin Microbiol Infect 2011;17(Suppl 6):1-24. doi:10. 1111/j. 1469-0691. 2011. 03602. x
40. Guyatt GH, Oxman AD, Vist GE, et al, GRADE Working Group. GRADE: An emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008;336:924-6. doi:10. 1136/ bmj. 39489. 470347. AD
41. Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet 2020;395:683-4. doi:10. 1016/ S0140-6736(20)30361-5